S'abonner

Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy - 04/02/21

Doi : 10.1016/j.jaci.2020.10.035 
Hanisah Sharif, MSc a, b, c, Swati Acharya, PhD d, Gopal Krishna R. Dhondalay, PhD d, Gilda Varricchi, MD, PhD a, e, Shoshanna Krasner-Macleod, BSc a, Wannada Laisuan, MD a, b, Amy Switzer, PhD a, Madison Lenormand, MSc a, b, Elena Kashe, MD a, Rebecca V. Parkin, BSc a, b, Yi Yi, MSc a, b, Merve Koc, MSc a, b, Oleksandra Fedina, MSc a, Gemma Vilà-Nadal, MD a, Gianni Marone, MD f, Aarif Eifan, MD a, Guy W. Scadding, MD, PhD a, David J. Fear, PhD g, Kari C. Nadeau, MD, PhD d, Stephen R. Durham, MD, FRCP a, Mohamed H. Shamji, PhD, FAAAAI a, b,
a Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London, United Kingdom 
b Asthma UK Centre in Allergic Mechanisms of Asthma, London, Imperial College London, London, United Kingdom 
c PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam 
d Sean N. Parker Center for Asthma and Allergy Research, Department of Medicine, Stanford University, Stanford, Calif 
e Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy 
f Division of Clinical Immunology and Allergy, Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy 
g Asthma UK Centre in Allergic Mechanisms of Asthma, Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King’s College London, London, United Kingdom 

Corresponding author: Mohamed H. Shamji, PhD, FAAAAI, Immunomodulation and Tolerance Group, Allergy & Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.Immunomodulation and Tolerance GroupAllergy & Clinical ImmunologyInflammationRepair and DevelopmentNational Heart and Lung InstituteFaculty of MedicineImperial College LondonLondonSW7 2AZUK

Abstract

Background

Allergen-specific immunotherapy is a disease-modifying treatment that induces long-term T-cell tolerance.

Objective

We sought to evaluate the role of circulating CXCR5+PD-1+ T follicular helper (cTFH) and T follicular regulatory (TFR) cells following grass pollen subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) and the accompanying changes in their chromatin landscape.

Methods

Phenotype and function of cTFH cells were initially evaluated in the grass pollen-allergic (GPA) group (n = 28) and nonatopic healthy controls (NAC, n = 13) by mathematical algorithms developed to manage high-dimensional data and cell culture, respectively. cTFH and TFR cells were further enumerated in NAC (n = 12), GPA (n = 14), SCIT- (n = 10), and SLIT- (n = 8) treated groups. Chromatin accessibility in cTFH and TFR cells was assessed by assay for transposase-accessible chromatin sequencing (ATAC-seq) to investigate epigenetic mechanisms underlying the differences between NAC, GPA, SCIT, and SLIT groups.

Results

cTFH cells were shown to be distinct from TH2- and TH2A-cell subsets, capable of secreting IL-4 and IL-21. Both cytokines synergistically promoted B-cell class switching to IgE and plasma cell differentiation. Grass pollen allergen induced cTFH-cell proliferation in the GPA group but not in the NAC group (P < .05). cTFH cells were higher in the GPA group compared with the NAC group and were lower in the SCIT and SLIT groups (P < .01). Time-dependent induction of IL-4, IL-21, and IL-6 was observed in nasal mucosa following intranasal allergen challenge in the GPA group but not in SCIT and SLIT groups. TFR and IL-10+ cTFH cells were induced in SCIT and SLIT groups (all, P < .01). ATAC-seq analyses revealed differentially accessible chromatin regions in all groups.

Conclusions

For the first time, we showed dysregulation of cTFH cells in the GPA group compared to NAC, SCIT, and SLIT groups and induction of TFR and IL-10+ cTFH cells following SCIT and SLIT. Changes in the chromatin landscape were observed following allergen-specific immunotherapy in cTFH and TFR cells.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : Allergy, seasonal allergic rhinitis, allergen-specific immunotherapy, T follicular helper cells, T follicular regulatory cells, chromatin accessibility, ATAC-seq

Abbreviations used : AIT, CSR, cTFH, CTLA-4, GC, GO, GPA, HDM, MAPK, NAC, SAR, SCIT, SLIT, SPADE, TFH, TFR, Treg


Plan


 This research was funded by Royal Brompton Hospital charity research funds, United Kingdom and National Institute for Health Research (NIHR) Biomedical Research Centre, United Kingdom.
 Disclosure of potential conflict of interest: K. C. Nadeau reports grants from the National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education, End Allergies Together, Allergenis, and Ukko Pharma; has research sponsorship by Novartis, Sanofi, Astellas, and Nestle; and personal fees from Regeneron, Astrazeneca, ImmuneWorks, and Cour Pharmaceuticals. S. R. Durham reports grants from Immune Tolerance Network, NIAID, Regeneron, Biotech Tools, and ALK; nonfinancial support from ALK, during the conduct of the study; personal fees from Anergis, Circassia, Biomay, Merck, Allergy Therapeutics, ALK, med Update GmbH; and grants from Food Standards Agency, UK, and the National Institute of Health Research UK; outside of the submitted work. M. H. Shamji reports grants and personal fees from ASIT Biotech S.A., ALK, Regeneron, Merck, and Immune Tolerance Network, and personal fees from ASIT Biotech S.A., ALK, and Allergopharma, outside of the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.


© 2020  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 147 - N° 2

P. 663-676 - février 2021 Retour au numéro
Article précédent Article précédent
  • Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry
  • Wojciech Francuzik, Franziska Ruëff, Andrea Bauer, Maria Beatrice Bilò, Victoria Cardona, George Christoff, Sabine Dölle-Bierke, Luis Ensina, Montserrat Fernández Rivas, Thomas Hawranek, Jonathan O'B Hourihane, Thilo Jakob, Nicos G. Papadopoulos, Claudia Pföhler, Iwona Poziomkowska-G?sicka, Xavier Van der Brempt, Kathrin Scherer Hofmeier, Regina Treudler, Nicola Wagner, Bettina Wedi, Margitta Worm
| Article suivant Article suivant
  • Unsupervised modeling and genome-wide association identify novel features of allergic march trajectories
  • Stanislaw J. Gabryszewski, Xiao Chang, Jesse W. Dudley, Frank Mentch, Michael March, John H. Holmes, Jason Moore, Robert W. Grundmeier, Hakon Hakonarson, David A. Hill

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.